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Abstract
The aim of this study was to genetically characterize clinical isolates from patients diag-
nosed withMycobacterium avium lung disease and to investigate the clinical significance.
Multi-locus sequencing analysis (MLSA) and pattern of insertion sequence analysis ofM.
avium isolates from 92 Korean patients revealed that all isolates wereM. avium subspecies
hominissuis. In hsp65 sequevar analysis, codes 2, 15, and 16 were most frequently found
(88/92) with similar proportions among cases additionally two isolates belonging to code N2
and an unreported code were identified, respectively. In insertion element analysis, all iso-
lates were IS1311 positive and IS900 negative. Four of theM. avium subsp. hominissuis iso-
lates did not harbor IS1245 and 1 of theM. avium isolates intriguingly harbored DT1, which
is thought to be aM. intracellulare-specific element.M. avium subsp. hominissuis harboring
ISMav6 is prevalent in Korea. No significant association between clinical manifestation and
treatment response has been found in patients with the hsp65 code type and ISMav6, indi-
cating that no specific strain/genotype amongM. avium subsp. hominissuis organisms was
a major source ofM. avium lung disease. Interestingly, the presence of ISMav6 was corre-
lated with greater resistance to moxifloxacin. Conclusively, the genotype of KoreanM.
avium subsp. hominissuis isolates is not a disease determinant responsible for lung disease
and specific virulent factors ofM. avium subsp. hominissuis need to be investigated further.
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Introduction
A rise in the incidence of pulmonary disease caused by nontuberculous mycobacteria (NTM)
has been reported worldwide [1, 2].Mycobacterium avium complex (MAC) is the most fre-
quent etiology of NTM lung disease [3]. MAC initially included two species,M. avium andM.
intracellulare.M. avium is the most clinically significant species for humans and animals
within the MAC and is divided into four subspecies:M. avium subsp. avium,M. avium subsp.
hominissuis,M. avium subsp. paratuberculosis, andM. avium subsp. silvaticum [4, 5].
Although subspecies ofM. avium in different geographic regions or populations may have
different levels of virulence due to co-evolutionary processes, consequently leading to varying
epidemiological dominance, most cases ofM. avium human disease are due toM. avium
subsp. hominissuis. Recently, lymphadenitis patients in France were found to be infected by
onlyM. avium subsp. hominissuis amongM. avium subspecies [6]. More recently, a subspecies
identification analysis ofM. avium clinical strains in the USA showedM. avium subsp. homi-
nissuis to be the dominantM. avium subspecies (92.6%), followed byM. avium subsp. avium
(7.4%) [7]. All GermanM. avium strains isolated from children and adults were identified as
M. avium subsp. hominissuis [8].
Many studies have emphasized the importance of taxonomy in distinguishing species and
subspecies of MAC because non-sequencing methods or 16S rRNA sequencing frequently fails
to distinguish closely related species [9, 10]. Multi-locus sequencing analysis (MLSA) has been
suggested as the new standard method for identifyingMycobacterium species that are not well
discriminated by 16S rRNA gene sequences alone [11–14].
The presence and distribution of various insertion sequences (IS) amongM. avium subspe-
cies have provided an unprecedented opportunity to define the genomic differences between
M. avium subspecies as well as to develop molecular typing methods with sufficient discrimina-
tory power to differentiateM. avium subspecies and isolates [15].
At our institution, the rpoB-PCR restriction fragment length polymorphism (RFLP) analysis
[PRA] method was used for species identification and diagnosis of MAC lung disease until
2009 [16–18]. To gain better insight intoM. avium lung disease in Korea, we used sequencing-
based methods for subspecies identification and genotyping and compared clinical characteris-
tics and treatment outcomes according to genotype. Furthermore, we investigated patterns of
antibiotic resistance according to mycobacterial genotype as well as the presence or absence of
ISMav6.
Materials and Methods
Study subjects
Clinical isolates from 92 patients with newly diagnosedM. avium lung disease from Jan. 2008
to Dec. 2009 at Samsung Medical Center (Seoul, Korea) were collected and stored. The data in
the present study are part of an ongoing prospective observational cohort study investigating
NTM lung disease (ClinicalTrials.gov Identifier: NCT00970801). The study protocol for iso-
lates collection and genotyping analysis was approved by the institutional review board of the
Samsung Medical Center (IRB approval 2008-09-016), and written informed consent was
obtained from all participants. All patients met the diagnostic criteria for NTM lung disease
[3]. All patients were immunocompetent and none of the patients tested positive for human
immunodeficiency virus. All isolates were collected before initiating antibiotic treatment for
NTM lung disease. Additionally,M. avium species initially identified by PRA based on the
rpoB gene at the time of diagnosis as previously described were used for subsequent analysis.
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Drug susceptibility test
Drug susceptibility testing was performed at the Korean Institute of Tuberculosis. The mini-
mum inhibitory concentrations (MICs) of clarithromycin (CLR) and moxifloxacin (MXF)
were determined using the broth microdilution method as described by the Clinical and
Laboratory Standards Institute (CLSI) [19]. Isolates with CLR MIC of32 μg/ml and MXF
MIC of4 μg/ml were considered to be resistant, according to the guidelines of the CLSI [19].
Molecular characterization ofM. avium clinical isolates by MLSA
M. avium strains were propagated in Middlebrook 7H9 broth (Difco Laboratories, Detroit, MI,
USA) supplemented with 10% (vol/vol) oleic acid-albumin-dextrose-catalase (OADC; BD
Diagnostics, Sparks, MD, USA). Mycobacterial DNA was extracted using a DNeasy Blood and
Tissue Kit according to the manufacturer’s instructions (Qiagen, Valencia, CA, USA). MLSA
including hsp65, rpoB, and 16S rRNA fragments was carried out using PCR primer sets as
described previously [20–22]. The PCR products of target genes were subjected to sequence
analysis. The nucleotide sequences of these genes were compared with data reported by BLAST
analysis (http://www.ncbi.nlm.nih.gov) against sequences fromM. avium subspecies type and
related strains.M. avium subsp. avium ATCC 25291,M. avium subsp. hominissuis 104,M.
avium subsp. paratuberculosis K-10, andM. avium subsp. silvaticum ATCC 49884 were used
as reference strains. For phylogenetic analysis, sequences were trimmed using the CLUS-
TAL-Wmultiple sequence alignment program [23]. Phylogenetic trees were obtained from
DNA sequences utilizing the neighbor-joining method and Kimura’s two parameter distance
correction model with 1,000 bootstrap replications supported by MEGA 6.0 software [24].
hsp65 code analysis
hsp65 code analysis was performed as previously described [25]. hsp65 gene PCR products
were subjected to sequence analysis. The nucleotide sequences of the hsp65 gene were com-
pared with data reported by BLAST analysis (http://www.ncbi.nlm.nih.gov) against theM.
avium type and related strains. hsp65 codes were classified according to previously reported
papers [25–27].
Insertion sequences element analysis
Multiplex PCR was performed to detect three target genes, IS900, IS1311, and DT1 using previ-
ously described methods [28]. A previously described primer set was used for the IS1245 inser-
tion element [29]. The presence of ISMav6 was determined by PCR followed by sequencing
analysis using a previously described primer set [26]. PCR products of insertion elements were
sequenced and the existence of a specific insertion element in each strain was confirmed. DNA
isolated fromM. abscessus ATCC 19977,M. tuberculosisH37Rv ATCC 27294, andM. gastri
ATCC 15754 were used as negative controls for each primer set in each PCR run.
Statistics
All data are presented as median and interquartile range for continuous variables and as num-
ber (percentage) for categorical variables. Data were compared using the Mann-Whitney U test
for continuous variables and the chi-squared or Fisher’s exact test for categorical variables. The
Mantel-Haenszel test for categorical variables was used to compare each hsp65 code or the
presence of ISMav6 across resistant levels (susceptible, intermediate, resistant) of each drug
[30]. Statistical analyses were performed using SAS 9.1 (SAS Institute Inc., Cary, NC, USA)
and a P-value less than 0.05 was considered statistically significant.
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Results
Subspecies identification ofM. avium clinical isolates by MLSA
Isolates from 92 patients diagnosed withM. avium lung disease were re-identified. The 16S
rRNA sequences ofM. avium subsp. hominissuis are identical to those of theM. avium subsp.
avium,M. avium subsp. paratuberculosis, andM. avium subsp. silvaticum. All isolates were
identified asM. avium based on 16S rRNA sequencing. The rpoB sequences of 76 isolates were
identical to those of theM. avium subsp. hominissuis type strain (GenBank accession no.
CP000479) and clinical strain (GenBank accession no. AP012555) (S1 Fig). A total of 10 iso-
lates showed a 1-bp mismatch (99.9% similarity) in a 711-bp fragment of the rpoB gene ofM.
avium subsp. hominissuis type strain (GenBank accession no. CP000479). The other 6 isolates
were identical to those of theM. avium subsp. avium type strain (GenBank accession no.
GQ153306). However, the nearly complete hsp65 sequences of all isolates, except 4 isolates,
were identical only to those of theM. avium subsp. hominissuis type strain (GenBank accession
no. CP000479) and clinical strains (GenBank accession nos. AP012555 and DQ284766) (Fig
1). Each pair of the 4 isolates were 99.8% (1413/1416) and 99.7% (1412/1416) similar to the
hsp65 sequences of theM. avium subsp. hominissuis type strain (GenBank accession no.
CP000479). The hsp65 sequences ofM. avium subsp. hominissuis were different (6-bp mis-
matches) from those of theM. avium subsp. avium type strain (GenBank accession no.
DQ284768). Phylogenetic analysis based on the concatenated hsp65 and rpoB sequences from
all isolates and from those of closely related species within the MAC showed that all isolates
belong toM. avium subsp. hominissuis (Fig 2). Therefore, all isolates were identified asM.
avium subsp. hominissuis using MLSA.
Distribution of hsp65 codes inM. avium subsp. hominissuis strains
In total, the 92 isolates were classified into five different hsp65 sequevars. There were no isolates
classified to hsp65 code 4, theM. avium subsp. avium sequevar. Four of these sequevars were
well recognized asM. avium subsp. hominissuis type and clinical strains and 1 sequevar code
was newly identified in this study. The new sequevar was coded N7 (following the code name
given in the previous paper [N1-N3] [26] and accepted paper [N4-N6]) and two isolates were
classified as code N7. The distribution of hsp65 sequevars in the 92 isolates is shown in Table 1.
The major codes were 2, 15, and 16.
Detection of insertion sequence elements
All isolates were negative for IS900 (considered diagnostic forM. avium subsp. paratuberculo-
sis) [31] and positive for IS1311 (considered diagnostic for all members ofM. avium subspe-
cies) [32]. One isolate belonging to the new sequevar N7 possessed DT1 (considered diagnostic
forM. intracellulare andM. avium subsp. avium); the DT1 sequence of this isolate was simi-
lar (92% and 89% similarity) to those of theM. intracellulare clinical strain andM. avium sero-
type 2 (M. intracellulare) DT1 (GenBank accession nos. CP003491 and L04543), suggesting
that horizontal transfer of DT1 might occur fromM. intracellulare toM. avium. Among 92 iso-
lates, 88 (96%) were positive for IS1245 (considered to be limited toM. avium subsp. avium,
M. avium subsp. hominissuis, andM. avium subsp. silvaticum) [5, 33, 34] and the other 4 iso-
lates did not harbor IS1245. Interestingly, 56 (61%) isolates possessed ISMav6. The code 15
sequevar showed a significantly higher prevalence of ISMav6 (84%) than did the other codes
(Table 1).
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Fig 1. hsp65 sequence-based phylogenetic tree using the neighbor-joiningmethod with Kimura’s two-parameter distance correctionmodel.
Bootstrap analyses determined from 1,000 replicates are indicated at the nodes. Bar, 0.5% difference in nucleotide sequence. GenBank accession numbers
are given in parentheses.
doi:10.1371/journal.pone.0148917.g001
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Fig 2. Phylogenetic tree based on concatenated rpoB and hsp65 sequences using the neighbor-
joiningmethod with Kimura’s two-parameter distance correction model. Bootstrap analyses
determined from 1,000 replicates are indicated at the nodes. Bar, 0.5% difference in nucleotide sequence.
GenBank accession numbers are shown in Fig 1 and S1 Fig.
doi:10.1371/journal.pone.0148917.g002
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Relatedness of clinical characteristics, treatment response, and drug
susceptibility to hsp65 codes and presence/absence of ISMav6
We analyzed clinical characteristics and treatment response among 3 major codes (code 2, 15,
and 16). There were no significant differences in clinical features among the 3 groups (S1 and
S2 Tables). We also analyzed clinical characteristics and treatment response according to the
presence of ISMav6. There were no significant differences in clinical features between those
with and without ISMav6 (S3 and S4 Tables). The association of genotype and the presence of
ISMav6 with drug susceptibility patterns in theM. avium subsp. hominissuis isolates was evalu-
ated for CLR and MXF. Drug susceptibility test were performed in 72 and 71 patients for CLR
and MXF, respectively. None of the hsp65 codes showed trends in drug susceptibility levels
(data not shown); however, the presence of ISMav6 was correlated with greater resistance to
MXF (Table 2).
Discussion
In this study, clinical isolates from 92 patients previously diagnosed withM. avium lung disease
over a two-year period were further analyzed. Species identification was initially performed by
Table 1. Identification of the novel hsp65 sequevar code and distribution of hsp65 codes and insertion elements in this study.
hsp65 codea Nucleotide at the indicated base pair position (hsp65)b n (%) n (%) of isolates
324 645 927 1128 1218 1269 1272 1350 1536 IS900 IS1245 IS1311 DT1 ISMav6
Code 2 T C C C G G C G G 32 (35) 0 32 32 0 15 (47)
Code 15 C • T • A • • • A 25 (27) 0 22 25 0 21 (84)
Code 16 C • T • A • • • • 31 (34) 0 31 31 0 18 (58)
Code N2 • • T • • • • • • 2 (2) 0 1 2 0 1 (50)
Code N7c C • • • • • G • • 2 (2) 0 2 2 1 1 (50)
Total 92 (100) 0 88 92 1 56 (61)
a Classiﬁcation according to previously reported papers [25–27].
b
• indicates the same base pair as in code 2.
c New code type found in this study designated code N7.
doi:10.1371/journal.pone.0148917.t001
Table 2. Association between presence of ISMav6 and antibiotic resistance.
Drug susceptibility test Detection of ISMav6 P-value for trend test
ISMav6 (+) ISMav6 (-) ISMav6 (+) vs. ISMav6 (-)
CLR 0.375
S 42 27
I 1 0
R 2 0
MXF 0.003
S 17 17
I 9 9
R 18 1
Data are presented as numbers.
Because drug susceptibility testing was not performed in all patients, the sum of the individual categories is less than 92.
Deﬁnition of abbreviations: CLR = clarithromycin; MXF = moxiﬂoxacin; S = susceptible; I = intermediate; R = resistant.
doi:10.1371/journal.pone.0148917.t002
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a non-sequencing method and then species were re-identified using a sequencing method.
Among the 92 isolates identified asM. avium by PRA at the time of diagnosis, all isolates were
precisely identified asM. avium subsp. hominissuis.
In hsp65 sequevar analysis, the major codes were 2, 15, and 16 (35%, 27%, and 34%, respec-
tively). Among Japanese clinical isolates, the main codes were 2 (63/146, 43%) and 15 (50/146,
34%), followed by 16 (9/146, 6%) [26]. The prevalence of code 16 in Korea was higher than in
Japan.
ISMav6 is a novel IS recently reported in the genetic characterization of Japanese human
clinical isolates [27]. In the present study, the prevalence of ISMav6 in Korean patients withM.
avium lung disease was 61%. Interestingly, more clinical isolates with hsp65 code 15 harbored
ISMav6 (84%, 21/25) than isolates with hsp65 code 2 and code 15 (47% and 58%, respectively).
Also, both hsp65 code 15 and ISMav6 have rarely been reported in the literature except in
Japan. In Germany, oneM. avium subsp. hominissuis strain with hsp65 code 15 harboring
ISMav6 was reported [8]. The high proportion of ISMav6 inM. avium subsp. hominissuis
strains from Korea and Japan is thought to be a specific genetic feature. Thus, both hsp65 code
15 and ISMav6may be related to the epidemiological diversity ofM. avium clinical strains.
In general, DT1 is present inM. intracellulare and not present inM. avium subsp. hominis-
suis. OneM. avium subsp. hominissuis isolates possessed DT1 in this study, which is a novel
observation. Since a number of different IS elements have been described in various NTM spe-
cies, species-specific IS elements have been revisited for MAC identification [28, 29, 35]. IS ele-
ments are mobile by nature, so there is a risk that similar elements will be found in unrelated
bacteria because of mobility to or from MAC organisms. For example, natural occurrence of
horizontal transfer ofM. avium-specific IS1245 toM. kansasii has been reported [36]. Thus,
the use of insertion sequences for species-specific markers should be more carefully conducted
because it may influence molecular diagnosis and, consequently, treatment outcomes.
Kikuchi et al. reported that a variable number of tandem repeats (VNTR)-genotyping of 37
M. avium clinical isolates was associated with the progression ofM. avium lung disease in
Japan [37]. However, our study, which included more than 100 clinical isolates, did not identify
any association between theM. avium VNTR genotype and disease progression ofM. avium
lung disease [38]. In the present study, disease progression was defined as when patients with
M. avium lung disease require antibiotic treatment due to worsening symptoms, deteriorating
chest radiograph features and microbiological findings within 2 years of diagnosis [39].
There was no difference in clinical characteristics and treatment response according to
hsp65 sequevar codes and ISMav6, in agreement with previous VNTR-based observations that
there was no association between the genotype and clinical characteristics of Korean patients
[38]. Interestingly, the presence of ISMav6 was associated with drug resistance to MXF in this
study. Tatano et al. reported an association between the VNTR genotype and susceptibility to
quinolones and EMB [40]. Dvorska et al. found no relationship between IS1311 and IS1245-
based RFLP genotypes and drug susceptibility in MAC isolates [41]. These findings suggest
that some genetic factors may influence the acquisition of drug resistance and ISMav6may be
a genetic factor associated with drug resistance. As far as we know, this is the first study to sug-
gest an association between genotypes according to hsp65 codes and ISMav6 and clinical fea-
tures with drug susceptibility. Our results indicate that specific genotypes amongM. avium
subsp. hominissuis organisms are not predominantly responsible forM. avium lung disease in
Korea and further analysis of ISMav6 (i.e. the location of ISMav6 in the genome ofM. avium
isolates) will help identify relationships between genetic features and drug susceptibility.
The present study has some limitations. First, this study was conducted at a single center
and was performed on a referral basis with final analysis of only a small number of Korean
patients; therefore, caution should be used when attempting to generalize our findings. Second,
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this study was preliminary because we did not investigate the specific genes associated with
drug resistance. Thus, further precise drug resistance typing of rpoB and gyrA/B with a large
number of isolates will provide a better understanding of the association betweenM. avium
subsp. hominissuis genotypes and drug resistance.
Nevertheless, to the best of our knowledge, this is the first report to investigate the link
between ISMav6 and drug resistance to MXF inM. avium subsp. hominissuis strains from
Korean patients. Future studies of informative and valuable genetic factors related toM. avium
lung disease should be conducted in both the pathogen and host.
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